Now in its third year, the trial is led by The Wistar Institute in collaboration with INOVIO, AstraZeneca, and clinical investigators at the University of Pennsylvania. It is funded by the Coronavirus ...

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

Biopharma companies require optimal clone yields to ensure maximum concentration and effectiveness of these therapeutic ...

Inovio (INO) announced promising interim results from an ongoing Phase 1 proof-of-concept trial evaluating DMAbs for COVID-19. In the trial, ...

INOVIO (NASDAQ: INO) has announced notable interim findings from a Phase 1 clinical trial testing DNA-encoded monoclonal ...

Introduction: the need for advanced monitoring in shake flasks. Shake flasks have been a cornerstone of biotechnological ...

OTR has been used for microbial fermentation but is difficult to measure accurately with conventional methods for mammalian cell cultivation.

Results saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAB in their systems.

As Emergent BioSolutions continues to pawn off manufacturing real estate in its pivot from production specialist to full-time ...

As Chief Operating Officer of Bio Usawa, Dr. Lukulay will oversee the company’s operations, driving innovation, scalability, and efficiency in the production of monoclonal antibodies.

CEPI is providing US$4.5 million to non-profit Fondazione Biotecnopolo di Siena (FBS) for proof-of-concept research that will ...